Myoglobin as a model system for designing heme protein based blood substitutes

Biophysical Chemistry

Volumn 98, Issue 1-2, 2002, Pages 127-148

  Dou, Yi ^a   Maillett, David H ^a   Eich, Raymund F ^a   Olson, John S ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

Blood substitutes; Heme proteins; Mb engineering

Indexed keywords

BLOOD SUBSTITUTE; HEMOPROTEIN; MYOGLOBIN; NITRIC OXIDE; RECOMBINANT HEMOGLOBIN;

ARTICLE; CRYSTAL STRUCTURE; HUMAN; LIGAND BINDING; MOLECULAR MODEL; OXYGEN AFFINITY; OXYGENATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS;

ANIMALS; BLOOD PRESSURE; BLOOD SUBSTITUTES; DRUG DESIGN; ESCHERICHIA COLI; HEMEPROTEINS; HEMOGLOBINS; HUMANS; KINETICS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MYOGLOBIN; NITRIC OXIDE; OXYGEN; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; THERMODYNAMICS; WHALES;

CETACEA; PHYSETER CATODON; SUS SCROFA;

EID: 0037054809     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(02)00090-X     Document Type: Article

References (98)

1. Carbon monoxide: A putative neural messenger
2. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins
3. Mechanism of NO-induced oxidation of myoglobin and hemoglobin
4. - under argon and in air
5. Nitric oxide moves myoglobin centre stage
6. Nitric oxide, cytochrome-c oxidase and myoglobin
7. Myoglobin: A pseudo-enzymatic scavenger of nitric oxide
8. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation
9. Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli
10. Cloning, expression in Escherichia coli, and reconstitution of human myoglobin
11. High-level expression of sperm whale myoglobin in Escherichia coli
12. Apomyoglobin as a molecular recognition surface: Expression, reconstitution and crystallization of recombinant porcine myoglobin in Escherichia coli
13. Formation of sulphmyoglobin during expression of horse heart myoglobin in Escherichia coli
14. Mechanisms of ligand recognition in myoglobin
15. Stability of myoglobin: A model for the folding of heme proteins
16. The D-helix in myoglobin and in the beta subunit of hemoglobin is required for the retention of heme
17. Structural factors governing hemin dissociation from metmyoglobin
18. Protein engineering strategies for designing more stable hemoglobin-based blood substitutes
19. Disruption of the heme iron-proximal histidine bond requires unfolding of deoxymyoglobin
20. The stabilities of mammalian apomyoglobins vary over a 600-fold range and can be enhanced by comparative mutagenesis
21. His64(E7)→Tyr apomyoglobin as a reagent for measuring rates of hemin dissociation
22. Dissociation of heme from myoglobin and cytochrome b5: Comparison of behavior in solution and the gas phase
23. New transfusion strategies: Red cell substitutes
24. Hemoglobin-based blood substitutes and the hazards of blood radicals
25. Blood substitutes for surgery and trauma: Efficacy and toxicity issues
26. Pharmacology of hemoglobin therapeutics
27. Reduced nitric oxide reactivity of a new recombinant human hemoglobin attenuates gastric dysmotility
28. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
29. Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties
30. Modulation of ligand binding in engineered human hemoglobin distal pocket
31. Alteration of axial coordination by protein engineering in myoglobin. Bisimidazole ligation in the His64→Val/Val68→His double mutant
32. The effects of amino acid substitution at position E7 (residue 64) on the kinetics of ligand binding to sperm whale myoglobin
33. Kinetic and spectroscopic characterization of an intermediate peroxynitrite complex in the nitrogen monoxide induced oxidation of oxyhemoglobin [corrected and republished article originally printed in FEBS Lett. 1998;439(1/2):85-88]
34. Kinetic and mechanistic studies of the NO*-mediated oxidation of oxymyoglobin and oxyhemoglobin
35. Stopped-flow, rapid mixing measurements of ligand binding to hemoglobin and red cells
36. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide
37. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension
38. Prediction of microcirculatory oxygen transport by erythrocyte/hemoglobin solution mixtures
39. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance
40. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary
41. 2 transport
42. 2 transport by hemoglobin in an in vitro capillary system
43. Stereochemistry of cooperative effects in haemoglobin
44. Mechanisms regulating the reactions of human hemoglobin with oxygen and carbon monoxide
45. 2, NO, and CO by electrostatic interactions with the bound ligand
46. 2 and CO binding to the alpha and beta subunits within the R and T states of human hemoglobin
47. Bound CO is a molecular probe of electrostatic potential in the distal pocket of myoglobin
48. 2 entry into and exit from myoglobin
49. Ligand migration in sperm whale myoglobin
50. Cavities in proteins: Structure of a metmyoglobin-xenon complex solved to 1.9 Å
51. Crystal structures of distal pocket mutants of myoglobin
52. 2 affinity and low autooxidation rate
53. Structural dynamics of ligand diffusion in the protein matrix: A study on a new myoglobin mutant Y(B10) Q(E7) R(E10)
54. Controlling ligand binding in myoglobin by mutagenesis
55. Reactions of nitric oxide with myoglobin
56. Peroxynitrite isomerization catalyzed by his64 myoglobin mutants
57. Nitric oxide dioxygenase: An enzymic function for flavohemoglobin
58. Nitric-oxide dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide and carbon monoxide inhibition
59. Steady-state and transient kinetics of Escherichia coli nitric-oxide dioxygenase (flavohemoglobin). The B10 tyrosine hydroxyl is essential for dioxygen binding and catalysis
60. Ascaris haemoglobin is a nitric oxide-activated 'deoxygenase' [see comments]
61. Constitutive and adaptive detoxification of nitric oxide in Escherichia coli. Role of nitric-oxide dioxygenase in the protection of aconitase
62. Nitric oxide and cytochrome c oxidase: Mechanisms of inhibition and NO degradation
63. On the mechanism by which vascular endothelial cells regulate their oxygen consumption
64. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione
65. Diffusion-limited reaction of free nitric oxide with erythrocytes
66. 2
67. Intravascular flow decreases erythrocyte consumption of nitric oxide
68. S-Nitrosohaemoglobin: A dynamic activity of blood involved in vascular control [see comments]
69. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient
70. Export by red blood cells of nitric oxide bioactivity
71. Disapirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial
72. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ishemic stroke
73. Hemoglobin and free radicals: Implications for the development of a safe blood substitute
74. Quaternary structure regulates hemin dissociation from human hemoglobin [published erratum appears in J Biol Chem 1997;272(38):24096]
75. The mechanism of autooxidation of myoglobin
76. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells
77. Phlebotomy of 500 or 750 milliliters of whole blood followed by isovolemic hemodilution or autologous transfusion yields similar hemodynamic, hematologic, and biochemical effects
78. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans
79. Construction of artificial methemoglobin reduction systems in Hb vesicles
80. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties [see comments]
81. Artificial blood: Ancient dream, modern enigma [news; Comment]
82. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: Implications for the design of hemoglobin-based oxygen carriers
83. Prediction of oxygen transport rates in blood flowing in large capillaries
84. Lowered nitric oxide reactivity decreases vasoconstriction induced by recombinant human hemoglobin [Abstr. presentation]
85. Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity
86. Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery
87. Microvascular oxygen distribution: Effects due to free hemoglobin in plasma
88. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model
89. Structural and functional effects of apolar mutations of the distal valine in myoglobin
90. Novel recombinant hemoglobin, rHb (beta N108Q), with low oxygen affinity, high cooperativity, and stability against autoxidation
91. Additivity of mutational effects in proteins
92. The effects of E7 and E11 mutations on the kinetics of ligand binding to R state human hemoglobin
93. Interactions among residues CD3, E7, E10, and E11 in myoglobins: Attempts to simulate the ligand binding properties of Aplysia myoglobin
94. A double mutant of sperm whale myoglobin mimics the structure and function of elephant myoglobin
95. Solution and crystal structures of a sperm whale myoglobin triple mutant that mimics the sulfide-binding hemoglobin from Lucina pectinata
96. High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin